An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Perimembranous Ventricular Septal Defect
Interventions
DEVICE

Transcatheter device closure of perimembranous ventricular septal defects (PmVSDs)

Transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using an occluder device either specifically designed for this purpose or used off-label.

Trial Locations (18)

Unknown

Copenhagen University Hospital, Rigshospitalet, Copenhagen

University Hospital of Bordeaux, Bordeaux

Marie Lannelongue Hospital, Le Plessis-Robinson

Lille University Hospital, Lille

Toulouse University Hospital, Toulouse

University Children's Hospital, Tübingen

National Cardiovascular Center of Harapan Kita, Jakarta

Rajaie Cardiovascular, Medical and Research Center, Tehran

Hôtel-Dieu de France University Medical Center, Beirut

Hospital de Especialidades Pediátricas, Chiapas

The Children's Hospital, Lahore

Silesian Center for Heart Diseases, Zabrze

Madinah Cardiac Center MCC, Madinah

Ankara City Hospital, Ankara

Koç University, Istanbul

Umraniye Training and Education Hospital, Istanbul

SBU Tepecik Training and Research Hospital, Izmir

Al Jalila Children's Speciality Hospital, Dubai

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT06823635 - An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects | Biotech Hunter | Biotech Hunter